McClung David

CFO McClung buys 4,819 shares of BCDA at $2.08; cluster pattern with 3 other insiders buying in past 14 days amid revenue collapse and losses.

David McClung, Chief Financial Officer of BioCardia, purchased 4,819 shares at $2.08 on 2025-06-30, increasing his holdings to 47,950 shares. This transaction occurs within a cluster pattern: 3 other insiders also bought within the past 14 days. Contemporaneous insider buying activity at a company in distress may signal either conviction in turnaround prospects or automatic trading. However, BioCardia's fundamentals present significant headwinds: revenue stands at $0.00 in the latest quarter, annual revenue growth contracted -87.8%, net income was $-2,712,000.00, and the market cap is only $10,770,011.20. The stock has declined -48.3% from its 52-week high of $4.02 and is down -8.0% over the past 30 days. McClung's cross-ticker track record shows 1 prior buy with a 30-day return of +3.4%, but at BioCardia specifically, his prior April 2025 purchase has not yet demonstrated measurable 90-day outcomes. The cluster buying pattern and the low share price warrant monitoring, but the absence of positive near-term momentum, severe revenue contraction, and lack of profitability suggest elevated execution risk.

CFO McClung bought 13,123 shares of BCDA at $1.90; cluster of 5 other insiders bought in 14 days amid revenue collapse and -67.6% drop from 52-week high

Chief Financial Officer David McClung purchased 13,123 shares at $1.90 on 2025-04-23, increasing his holdings from 30,008 shares to 43,131 shares (+43.7%). This purchase occurred during a period of severe operational distress: BioCardia reported zero revenue in the latest quarter and a negative net income of -1,737,000.00 for the most recent full fiscal year, with annual revenue contracting 87.8% year-over-year. The stock is down 67.6% from its 52-week high of $6.09 and has declined 22.8% over the preceding 30 days. Notably, this purchase was part of a coordinated cluster buy, with 5 other insiders also acquiring shares within the past 14 days, suggesting either a coordinated response to perceived undervaluation or alignment around a company initiative during a critical operational period.